RAC 3.31% $1.61 race oncology ltd

Ann: Impressive Preclinical Bisantrene Breast Cancer Results, page-106

  1. 2,676 Posts.
    lightbulb Created with Sketch. 10275
    Yes it is very strong - consistently seen in all the trials ( there have been over 40). This is not too surprising given Bisantrene was deliberately developed to be like the anthracyclines in action, but without the toxicity. Lederle spent a lot of time and money on developing Bisantrene.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.61
Change
-0.055(3.31%)
Mkt cap ! $273.4M
Open High Low Value Volume
$1.66 $1.68 $1.61 $271.5K 166.3K

Buyers (Bids)

No. Vol. Price($)
1 1996 $1.61
 

Sellers (Offers)

Price($) Vol. No.
$1.68 1305 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.